Brain Machine Interface Hardware Revenues to Reach $19 Billion by 2027 Driven by Medical Applications
Hampshire, UK - March 6, 2018 (Investorideas.com Newswire) A new study from Juniper Research has found that global hardware sales revenue from BMI (Brain Machine Interfaces) will reach $19 billion per annum by 2027, up from an estimated $2.4 billion in 2018. BMIs bridge the gap between technology and the brain, interpreting brain signals for the purpose of interpretation or control.
The study, Brain Machine Interfaces: Impact Assessments, Opportunities & Use Cases 2018-2027, found that medical uses will account for 78% of shipment revenues by 2027. This will be due to development of advanced medical uses, such as artificial vision and prosthetic control.
Read more in Juniper's complimentary whitepaper, Unlocking the Power of Brain Machine Interfaces.
Three Use Cases Offering the Greatest Potential
Juniper's study examined the emerging market, analysing metrics such as expected user impact, key barriers and ecosystem readiness. It identified three use cases with the highest potential to be:
- Concentration Monitoring;
- Cochlear Implants;
- Sleep Modification Tools.
The research found that the greatest impact of BMIs will be when used for concentration monitoring, where EEG (Electroencephalogram) technology can be leveraged to monitor fatigue. This is crucial for industrial businesses, which strive to improve safety and productivity.
Juniper predicted that heavy industry will use EEG to replace more expensive existing monitoring systems. Research author Nick Maynard explained: "EEG is more accurate than current wrist-based optical sensors for concentration monitoring, so adoption where concentration is crucial in high-risk environments is anticipated to be a big driver in the market."
Consumer Use Cases to Emerge
The research found that while shipments of BMI devices for consumer uses such as guided meditation account for a very low proportion of device shipments presently, of under 1% in 2018, the proportion will climb to over 6% of a much larger market in 2027. Juniper predicted that technology advancement in tandem with consumer virtual/mixed reality uptake would facilitate new interface paradigms when integrated. This higher proportion will be aided by the lower average sales price of these devices, just $270 in 2027, compared to $11,570 in the medical area.
Juniper Research provides research and analytical services to the global hi-tech communications sector, providing consultancy, analyst reports and industry commentary.
This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.